The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Benfotiamine Market Research Report 2025
Synopsis
Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer's disease, and alcohol dependence.
The global Benfotiamine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Benfotiamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Benfotiamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Benfotiamine include Klaire, Hamari, BioXera Pharma, Kimia Biosciences, AOR, Country Life Vitamins, Neurohacker Collective, XY Mogen and Pharmaffiliates, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Benfotiamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benfotiamine.
Report Scope
The Benfotiamine market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Benfotiamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Benfotiamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Klaire
Hamari
BioXera Pharma
Kimia Biosciences
AOR
Country Life Vitamins
Neurohacker Collective
XY Mogen
Pharmaffiliates
Hangzhou Eastbiopharm
Basil Pharmaceuticals
Ami Lifesciences
Kaival Chemicals
Segment by Type
Pharma Grade
Food Grade
Segment by Application
DietarySupplement
Diabetic Neuropathy
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Benfotiamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Benfotiamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Benfotiamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer's disease, and alcohol dependence.
The global Benfotiamine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Benfotiamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Benfotiamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Benfotiamine include Klaire, Hamari, BioXera Pharma, Kimia Biosciences, AOR, Country Life Vitamins, Neurohacker Collective, XY Mogen and Pharmaffiliates, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Benfotiamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benfotiamine.
Report Scope
The Benfotiamine market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Benfotiamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Benfotiamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Klaire
Hamari
BioXera Pharma
Kimia Biosciences
AOR
Country Life Vitamins
Neurohacker Collective
XY Mogen
Pharmaffiliates
Hangzhou Eastbiopharm
Basil Pharmaceuticals
Ami Lifesciences
Kaival Chemicals
Segment by Type
Pharma Grade
Food Grade
Segment by Application
DietarySupplement
Diabetic Neuropathy
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Benfotiamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Benfotiamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Benfotiamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Benfotiamine Market Overview
1.1 Product Definition
1.2 Benfotiamine Segment by Type
1.2.1 Global Benfotiamine Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Pharma Grade
1.2.3 Food Grade
1.3 Benfotiamine Segment by Application
1.3.1 Global Benfotiamine Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 DietarySupplement
1.3.3 Diabetic Neuropathy
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Benfotiamine Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Benfotiamine Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Benfotiamine Production Estimates and Forecasts (2019-2030)
1.4.4 Global Benfotiamine Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Benfotiamine Production Market Share by Manufacturers (2019-2024)
2.2 Global Benfotiamine Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Benfotiamine, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Benfotiamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Benfotiamine Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Benfotiamine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Benfotiamine, Product Offered and Application
2.8 Global Key Manufacturers of Benfotiamine, Date of Enter into This Industry
2.9 Benfotiamine Market Competitive Situation and Trends
2.9.1 Benfotiamine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Benfotiamine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Benfotiamine Production by Region
3.1 Global Benfotiamine Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Benfotiamine Production Value by Region (2019-2030)
3.2.1 Global Benfotiamine Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Benfotiamine by Region (2025-2030)
3.3 Global Benfotiamine Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Benfotiamine Production by Region (2019-2030)
3.4.1 Global Benfotiamine Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Benfotiamine by Region (2025-2030)
3.5 Global Benfotiamine Market Price Analysis by Region (2019-2024)
3.6 Global Benfotiamine Production and Value, Year-over-Year Growth
3.6.1 North America Benfotiamine Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Benfotiamine Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Benfotiamine Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Benfotiamine Production Value Estimates and Forecasts (2019-2030)
4 Benfotiamine Consumption by Region
4.1 Global Benfotiamine Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Benfotiamine Consumption by Region (2019-2030)
4.2.1 Global Benfotiamine Consumption by Region (2019-2024)
4.2.2 Global Benfotiamine Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Benfotiamine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Benfotiamine Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Benfotiamine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Benfotiamine Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Benfotiamine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Benfotiamine Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Benfotiamine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Benfotiamine Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Benfotiamine Production by Type (2019-2030)
5.1.1 Global Benfotiamine Production by Type (2019-2024)
5.1.2 Global Benfotiamine Production by Type (2025-2030)
5.1.3 Global Benfotiamine Production Market Share by Type (2019-2030)
5.2 Global Benfotiamine Production Value by Type (2019-2030)
5.2.1 Global Benfotiamine Production Value by Type (2019-2024)
5.2.2 Global Benfotiamine Production Value by Type (2025-2030)
5.2.3 Global Benfotiamine Production Value Market Share by Type (2019-2030)
5.3 Global Benfotiamine Price by Type (2019-2030)
6 Segment by Application
6.1 Global Benfotiamine Production by Application (2019-2030)
6.1.1 Global Benfotiamine Production by Application (2019-2024)
6.1.2 Global Benfotiamine Production by Application (2025-2030)
6.1.3 Global Benfotiamine Production Market Share by Application (2019-2030)
6.2 Global Benfotiamine Production Value by Application (2019-2030)
6.2.1 Global Benfotiamine Production Value by Application (2019-2024)
6.2.2 Global Benfotiamine Production Value by Application (2025-2030)
6.2.3 Global Benfotiamine Production Value Market Share by Application (2019-2030)
6.3 Global Benfotiamine Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Klaire
7.1.1 Klaire Benfotiamine Corporation Information
7.1.2 Klaire Benfotiamine Product Portfolio
7.1.3 Klaire Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Klaire Main Business and Markets Served
7.1.5 Klaire Recent Developments/Updates
7.2 Hamari
7.2.1 Hamari Benfotiamine Corporation Information
7.2.2 Hamari Benfotiamine Product Portfolio
7.2.3 Hamari Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Hamari Main Business and Markets Served
7.2.5 Hamari Recent Developments/Updates
7.3 BioXera Pharma
7.3.1 BioXera Pharma Benfotiamine Corporation Information
7.3.2 BioXera Pharma Benfotiamine Product Portfolio
7.3.3 BioXera Pharma Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.3.4 BioXera Pharma Main Business and Markets Served
7.3.5 BioXera Pharma Recent Developments/Updates
7.4 Kimia Biosciences
7.4.1 Kimia Biosciences Benfotiamine Corporation Information
7.4.2 Kimia Biosciences Benfotiamine Product Portfolio
7.4.3 Kimia Biosciences Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Kimia Biosciences Main Business and Markets Served
7.4.5 Kimia Biosciences Recent Developments/Updates
7.5 AOR
7.5.1 AOR Benfotiamine Corporation Information
7.5.2 AOR Benfotiamine Product Portfolio
7.5.3 AOR Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.5.4 AOR Main Business and Markets Served
7.5.5 AOR Recent Developments/Updates
7.6 Country Life Vitamins
7.6.1 Country Life Vitamins Benfotiamine Corporation Information
7.6.2 Country Life Vitamins Benfotiamine Product Portfolio
7.6.3 Country Life Vitamins Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Country Life Vitamins Main Business and Markets Served
7.6.5 Country Life Vitamins Recent Developments/Updates
7.7 Neurohacker Collective
7.7.1 Neurohacker Collective Benfotiamine Corporation Information
7.7.2 Neurohacker Collective Benfotiamine Product Portfolio
7.7.3 Neurohacker Collective Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Neurohacker Collective Main Business and Markets Served
7.7.5 Neurohacker Collective Recent Developments/Updates
7.8 XY Mogen
7.8.1 XY Mogen Benfotiamine Corporation Information
7.8.2 XY Mogen Benfotiamine Product Portfolio
7.8.3 XY Mogen Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.8.4 XY Mogen Main Business and Markets Served
7.7.5 XY Mogen Recent Developments/Updates
7.9 Pharmaffiliates
7.9.1 Pharmaffiliates Benfotiamine Corporation Information
7.9.2 Pharmaffiliates Benfotiamine Product Portfolio
7.9.3 Pharmaffiliates Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Pharmaffiliates Main Business and Markets Served
7.9.5 Pharmaffiliates Recent Developments/Updates
7.10 Hangzhou Eastbiopharm
7.10.1 Hangzhou Eastbiopharm Benfotiamine Corporation Information
7.10.2 Hangzhou Eastbiopharm Benfotiamine Product Portfolio
7.10.3 Hangzhou Eastbiopharm Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Hangzhou Eastbiopharm Main Business and Markets Served
7.10.5 Hangzhou Eastbiopharm Recent Developments/Updates
7.11 Basil Pharmaceuticals
7.11.1 Basil Pharmaceuticals Benfotiamine Corporation Information
7.11.2 Basil Pharmaceuticals Benfotiamine Product Portfolio
7.11.3 Basil Pharmaceuticals Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Basil Pharmaceuticals Main Business and Markets Served
7.11.5 Basil Pharmaceuticals Recent Developments/Updates
7.12 Ami Lifesciences
7.12.1 Ami Lifesciences Benfotiamine Corporation Information
7.12.2 Ami Lifesciences Benfotiamine Product Portfolio
7.12.3 Ami Lifesciences Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Ami Lifesciences Main Business and Markets Served
7.12.5 Ami Lifesciences Recent Developments/Updates
7.13 Kaival Chemicals
7.13.1 Kaival Chemicals Benfotiamine Corporation Information
7.13.2 Kaival Chemicals Benfotiamine Product Portfolio
7.13.3 Kaival Chemicals Benfotiamine Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Kaival Chemicals Main Business and Markets Served
7.13.5 Kaival Chemicals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Benfotiamine Industry Chain Analysis
8.2 Benfotiamine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Benfotiamine Production Mode & Process
8.4 Benfotiamine Sales and Marketing
8.4.1 Benfotiamine Sales Channels
8.4.2 Benfotiamine Distributors
8.5 Benfotiamine Customers
9 Benfotiamine Market Dynamics
9.1 Benfotiamine Industry Trends
9.2 Benfotiamine Market Drivers
9.3 Benfotiamine Market Challenges
9.4 Benfotiamine Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
